Originally posted by carslake
Novartis charges $10,000 per annum for its anti-retroviral drug, whereas India manufactures it for $70 per annum. Is it me or is Novartis making $9930
on every patient taking its treatment, can anyone justify that level of profit.
They made it, they get to decide what it sells for.
The problem is that india has unusual patent laws, they basically allow indian companies to take the result of another companies years of research,
investment, and expenditures, and make rip-offs of their product, which they then sell, on their own, for a proft.
Normally we'd call this 'stealing', but, on the other hand, people are dying.
The problem is that if the whole world did this, then we wouldn't have these medecines in the first place. You should notice, that the indian
pharmaceutical industry
isn't creating new drugs and treatments, becuase its not profitable.